Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma

Jason M Shohet1, M John Hicks, Sharon E Plon

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

Cancer Research
|February 28, 2002
PubMed

Insights

The MYCN oncogene directly increases MCM7 expression in neuroblastoma, a key protein for DNA replication. This finding sheds light on how MYCN drives tumor growth in these cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYCN oncogene amplification is a major negative prognostic factor in neuroblastoma.
  • Direct transcriptional targets of MYCN in neuroblastoma remain largely undefined.
  • Understanding MYCN's regulatory network is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify direct transcriptional targets of the MYCN oncogene in neuroblastoma.
  • To investigate the role of MCM7 in MYCN-amplified neuroblastoma.
  • To elucidate the mechanism by which MYCN influences DNA replication genes.

Main Methods:

  • Microarray analysis of RNA from neuroblastoma cell cultures.
  • Quantitative analysis of MCM7 RNA and protein expression.
  • Luciferase reporter assays to assess promoter activity.
  • Electrophoretic mobility shift assays (EMSA) to detect protein-DNA interactions.

Main Results:

  • MCM7 expression was 10-fold higher in MYCN-amplified neuroblastoma tumors compared to non-amplified tumors.
  • MCM7 RNA and protein levels were significantly increased in MYCN-amplified neuroblastoma cell lines and tumors.
  • MYCN induction in conditional cell lines led to increased MCM7 mRNA and protein levels.
  • Luciferase activity assays and EMSA confirmed direct transcriptional activation of MCM7 by MYCN.

Conclusions:

  • The MYCN oncogene directly activates MCM7, an essential gene for DNA replication, in neuroblastoma.
  • This direct activation of DNA replication genes by MYCN may contribute to neoplastic transformation and tumor progression.
  • Targeting the MYCN-MCM7 axis could represent a novel therapeutic strategy for MYCN-amplified neuroblastoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...